Table 2.
The number of subjects with oral Candida carriage pre-HSCT and 3, 6, 12, and 24 months post-HSCT
| Subjects | Pre-HSCT | 3 M | 6 M | 12 M | 24 M |
|---|---|---|---|---|---|
| Female; # of candida/ # of subjects; (%) | 23/82 (28.1%) | 10/38 (26.3%) | 12/38 (31.6%) | 13/33 (39.4%) | 4/9 (44.4%) |
| Male; # of candida/ # of subjects (%) | 37/118 (31.4%) | 12/48 (25.0%) | 18/47 (38.3%) | 20/42 (47.6%) | 4/8 (50.0%) |
| Total; # of candida/ # of subjects (%) | 60/200 (30.0%) | 22/86 (25.6%) | 30/85 (35.3%) | 33/75 (44. 0%) | 8/17 (47.1%) |